Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print Center calls for stronger federal regulation of genetic testing

Center calls for stronger federal regulation of genetic testing

November 30, 2005

The Genetics and Public Policy Center this week called on Mark McClellan, Administrator of the Centers for Medicare and Medicaid Services (CMS), to end years of delay in assuring the safety and accuracy of genetic testing by issuing a proposed rule to create a genetic testing specialty under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. The delay has meant that scientific and technological advances in genetic testing have outpaced the government's ability to provide adequate oversight, maintains the Center, which was established by The Pew Charitable Trusts through Johns Hopkins University.

CMS, an agency of the U.S. Department of Health and Human Services, administers standards for diagnostic laboratory testing, such as those used for blood sugar, urinalysis, or HIV infection, to ensure that the tests are accurate and reliable and that physical conditions at the laboratories meet certain expectations.




"For more than ten years, federal advisory committees have been calling upon the government to provide more oversight of genetic tests," the letter to McClellan from the Center notes. CMS responded to the growing sense of urgency to improve genetic testing oversight five years ago by issuing a Notice of Intent of proposed rulemaking that incorporated recommendations from a federal advisory group regarding development of a genetic testing specialty.

"More than five years later, nothing has been issued by (CMS)," the letter says. During the same period, the genetic testing industry has grown dramatically; today, more than 800 genetics tests are available clinically, and many more are in development. "These genetic tests may be the basis for profound life decisions, such as whether to undergo prophylactic mastectomy, terminate a pregnancy, or take a certain drug or certain dosage of a drug," according to the letter.

Under CLIA, CMS is charged with developing standards for how medical laboratory tests are conducted, the training and proficiency of laboratory personnel, and other standards to ensure the quality of clinical tests. The problem, says Center policy analyst Gail Javitt, an author of the letter, is that CLIA did not include a genetic testing specialty for the then-nascent field of genetic testing as part of its oversight regime.

"The absence of a specialty area for genetic testing with specifically tailored requirements for the now-burgeoning genetic testing industry hampers CLIA's ability to oversee the quality of genetic testing and adequately to ensure its safety," she writes. "We urge CMS to take immediate steps to issue proposed regulations for a genetic testing specialty."

The Center reviewed all the comments that were collected by CMS five years ago in response to the Notice of Intent, Javitt explains. "There were no showstoppers here in terms of issues central to the regulation," she says. "Rather, we found substantial support for the creation of a genetic testing specialty." There were specific concerns about a few of the proposed requirements detailed in the Notice of Intent, she explained, but these that could be left out of the final rule without unduly weakening the regulation. "A genetic testing specialty is achievable if it focuses on key quality requirements such as analytic and clinical validity of the tests and proficiency standards for laboratory personnel," she added.

"The government has been dragging its feet for more than 10 years about improving the quality of genetic testing," she said. "It's time to move swiftly to protect the American public and publish a proposed rule."

Genetics & Public Policy Center, Johns Hopkins Uni



Related Genetic Testing News Articles Genetic Testing News and Current Genetic Testing Events RSS Genetic Testing News and Current Genetic Testing Events RSS
No need for gene screens in breast cancer families
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.

Predicting the risk of a common fungal infection after stem cell transplantation
In silico genetic analysis in mice has led to the discovery of a gene affecting susceptibility to a severe fungal infection in transplant recipients.

Inherited melanoma risk: What you do know does help you
When people know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactively-much like those who have already been diagnosed with the potentially deadly disease.

UNC medical geneticist cautions against rushing into genetic testing
Just because scientific advances now allow individuals to learn their genetic make-up doesn't mean they should rush into genetic testing in hopes of making revolutionary improvements to their health, cautions a geneticist and practicing physician at the University of North Carolina at Chapel Hill.

Study finds it pays to be heart smart if considering hormone therapy
A research study has found that a simple blood test may indicate whether post-menopausal hormone therapies present an elevated risk of a heart attack.

Study Shows Gene Variations May Predict Risk of Breast Cancer in Women
According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman's risk of developing breast cancer.

Second breast cancer may be greater than thought for high-risk women without BRCA mutations
A preliminary analysis of ongoing research suggests that high-risk women with breast cancer who do not have a BRCA1/2 mutation may face a greater chance for developing a second breast cancer than previously thought. With the increased risk of cancer in these women, should sentinel node biopsy be considered at the time of prophylactic mastectomy, and how can women best be counseled after these findings?

American College of Medical Genetics makes genetic testing recommendations in new policy statement
Consumers are increasingly being marketed a broad range of genetic tests. Paternity tests at the drugstore-.Personal genome mapping-Gene tests to predict future baldness.

High anxiety?
Right now, about half of all people who take medicine for an anxiety disorder don't get much help from it. And doctors have no definitive way to predict who will, and who won't, benefit from each anti-anxiety prescription they write.

Many African-Americans have a gene that prolongs life after heart failure
About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.
More Genetic Testing News Articles


It's Not Just Your Genes!
by Ruth DeBusk, Yael Joffe

It's Not Just Your Genes! introduces you to the fascinating world of genomics. Genetic technologies are revolutionizing health care, and in order to take full advantage of the advances emerging from this field, you need to get comfortable with its language and concepts. Today we know that rather than viewing our genetic makeup as a hand of cards that have already been dealt, we have the power...



The Rising Curve: Long-Term Gains in IQ and Related Measures (Apa Science Volumes)

...written by leading experts in psychology, sociology, psychometrics, and nutrition...discusses the environmental and social factors that affect IQ, the upward trend in IQ scores worldwide, and much...



Multiple Testing Procedures with Applications to Genomics (Springer Series in Statistics)
by Sandrine Dudoit, Mark J. van der Laan

This book establishes the theoretical foundations of a general methodology for multiple hypothesis testing and discusses its software implementation in R and SAS. The methods are applied to a range of testing problems in biomedical and genomic research, including the identification of differentially expressed and co-expressed genes in high-throughput gene expression experiments, such as...



Genetic Ties and the Family: The Impact of Paternity Testing on Parents and Children

Genetic Ties and the Family brings together experts in history, law, ethics, philosophy, psychology, social work, and sociology to explore the tension between biological and social conceptions of parentage. The contributors consider the effect of DNA-based paternity testing on family relationships and discuss the ethical, legal, and social implications.These essays reflect the changing concepts...



Quality of Life and Human Difference: Genetic Testing, Health Care, and Disability (Cambridge Studies in Philosophy and Public Policy)

The role of quality assessments in social policy, especially health policy, and ethical and social issues raised by prenatal testing for disability are discussed in this analysis. A theme of the literature has been the role played by controversial assumptions about the quality of life of people with disabilities. This book turns the perspectives of disability scholars to issues that have largely...



Prospects for Antisense Nucleic Acid Therapy of Cancer And AIDS

Privacy and ethics in pediatric environmental health research--part I: genetic and prenatal testing.(Mini-Monograph): An article from: Environmental Health Perspectives
by Celia B. Fisher

This digital document is an article from Environmental Health Perspectives, published by Thomson Gale on October 1, 2006. The length of the article is 6472 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Federal privacy and confidentiality. (of fetus in prenatal diagnosis): An article from: The Hastings Center Report
by Jeffrey R. Botkin

This digital document is an article from The Hastings Center Report, published by Hastings Center on September 1, 1995. The length of the article is 7434 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.From the author:...

Society's diseases. (ethical aspects of prenatal genetic screening)(includes commentaries): An article from: The Hastings Center Report
by Diana Punales Morejon, Marsha Saxton

This digital document is an article from The Hastings Center Report, published by Hastings Center on May 1, 1996. The length of the article is 1736 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...

High-Dimensional Data Analysis in Oncology (Applied Bioinformatics and Biostatistics in Cancer Research)

Multivariate analysis is a mainstay of statistical tools in the analysis of biomedical data. It concerns with associating data matrices of n rows by p columns, with rows representing samples (or patients) and columns attributes of samples, to some response variables, e.g., patients outcome. Classically, the sample size n is much larger than p, the number of variables. The properties of...

© 2008 BrightSurf.com